A new phenomenon dubbed “quarantine myopia” is making waves in Australia in the wake of a Chinese study that found...
Read moreAn Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes...
Read moreAn ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Approximately...
Read moreOphthalmologists have documented what is believed to be the first reported case of permanent loss of visual acuity that may...
Read moreSwiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME)...
Read moreNovartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...
Read moreA grant from CooperVision has supported a team of researchers from the Terasaki Institute for Biomedical Innovation in Los Angeles...
Read moreSore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open...
Read moreResearchers have analysed the prevalence of COVID-19 in human post-mortem ocular tissues, highlighting the importance of the donor screening process....
Read moreRetina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited